These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31669236)

  • 1. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.
    Poulsen NS; Madsen KL; Hornsyld TM; Eisum AV; Fornander F; Buch AE; Stemmerik MG; Ruiz-Ruiz C; Krag TO; Vissing J
    Mitochondrion; 2020 Jan; 50():35-41. PubMed ID: 31669236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
    Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
    PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
    Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
    J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
    Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy.
    Dominguez-Gonzalez C; Badosa C; Madruga-Garrido M; Martí I; Paradas C; Ortez C; Diaz-Manera J; Berardo A; Alonso-Pérez J; Trifunov S; Cuadras D; Kalko SG; Blázquez-Bermejo C; Cámara Y; Martí R; Mavillard F; Martin MA; Montoya J; Ruiz-Pesini E; Villarroya J; Montero R; Villarroya F; Artuch R; Hirano M; Nascimento A; Jimenez-Mallebrera C
    Sci Rep; 2020 Jun; 10(1):10111. PubMed ID: 32572108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps.
    Sari K; Gencer ZK; Ede H; Gocmen AY; Kantekin Y
    Auris Nasus Larynx; 2016 Oct; 43(5):529-36. PubMed ID: 26795264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Other Myopathies.
    Hussain Y; Miller S
    Neurol Clin; 2020 Aug; 38(3):619-635. PubMed ID: 32703473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis.
    De Paepe B; Verhamme F; De Bleecker JL
    Cytokine; 2020 Mar; 127():154966. PubMed ID: 31901761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.
    Nohara S; Ishii A; Yamamoto F; Yanagiha K; Moriyama T; Tozaka N; Miyake Z; Yatsuga S; Koga Y; Hosaka T; Terada M; Yamaguchi T; Aizawa S; Mamada N; Tsuji H; Tomidokoro Y; Nakamagoe K; Ishii K; Watanabe M; Tamaoka A
    J Neurol Sci; 2019 Oct; 405():116429. PubMed ID: 31476622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure.
    Rosenberg BJ; Hirano M; Quinzii CM; Colantuoni E; Needham DM; Lederer DJ; Baldwin MR
    Thorax; 2019 Nov; 74(11):1099-1101. PubMed ID: 31534031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions.
    Forsström S; Jackson CB; Carroll CJ; Kuronen M; Pirinen E; Pradhan S; Marmyleva A; Auranen M; Kleine IM; Khan NA; Roivainen A; Marjamäki P; Liljenbäck H; Wang L; Battersby BJ; Richter U; Velagapudi V; Nikkanen J; Euro L; Suomalainen A
    Cell Metab; 2019 Dec; 30(6):1040-1054.e7. PubMed ID: 31523008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.
    Delaney NF; Sharma R; Tadvalkar L; Clish CB; Haller RG; Mootha VK
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8402-8407. PubMed ID: 28716914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
    Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
    Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial myopathy induces a starvation-like response.
    Tyynismaa H; Carroll CJ; Raimundo N; Ahola-Erkkilä S; Wenz T; Ruhanen H; Guse K; Hemminki A; Peltola-Mjøsund KE; Tulkki V; Oresic M; Moraes CT; Pietiläinen K; Hovatta I; Suomalainen A
    Hum Mol Genet; 2010 Oct; 19(20):3948-58. PubMed ID: 20656789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.